Board Members

President & CEO

Toru has more than 25 years of experience in pharmaceutical research and drug development at industry, academia and biotech companies. He joined LiberoThera in February 2019 as CTO and assigned as representative director and CEO in June 2020. Before joining LiberoThera, Toru led multiple antibody drug discovery projects at LivTech and Chiome Bioscience for about 10 years. He started his drug development career at KOWA company, involved in multiple GPCR projects including collaborative project with the University of Strathclyde in Glasgow, UK. Toru also worked at Okayama University graduate school of Medicine, Dentistry and Pharmaceutical Sciences as an assistant professor, and a director at a biotech startup. He obtained his BSc and MSc from the University of Tokyo and his PhD from the University of Strathclyde in Physiology and Pharmacology.
Director

Takehiko Sawabe, MBA

Director

Makoto Ohori, Ph.D.

Director

Sakae Asanuma, CFA, MBA

Director

Chihiro Yokota

Director

Mikio Arisawa, Ph.D.

Auditor

Kazuo Kawamura, Ph.D.